| Lyka Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.73 | 1.64 | 5.77 | 12.15 | 1.91 |
| Long Term Debt-Equity Ratio | 0.60 | 1.02 | 4.20 | 11.23 | 1.71 |
| Current Ratio | 1.25 | 0.68 | 0.62 | 0.84 | 0.83 |
| Fixed Assets | 0.69 | 0.50 | 0.98 | 0.41 | 0.35 |
| Inventory | 12.90 | 10.66 | 26.34 | 12.44 | 6.99 |
| Debtors | 4.96 | 4.64 | 11.96 | 7.55 | 2.25 |
| Interest Cover Ratio | 0.81 | 0.48 | 4.02 | 0.28 | -0.44 |
| PBIDTM (%) | 15.18 | 23.64 | 58.14 | 24.41 | -1.52 |
| PBITM (%) | 3.63 | 6.86 | 48.77 | 11.48 | -20.59 |
| PBDTM (%) | 10.67 | 9.28 | 46.02 | -16.62 | -48.18 |
| CPM (%) | 9.42 | 9.05 | 33.64 | -10.30 | -49.07 |
| APATM (%) | -2.13 | -7.73 | 24.28 | -23.23 | -68.14 |
| ROCE (%) | 0.00 | 0.00 | 35.98 | 0.00 | 0.00 |
| RONW (%) | 0.00 | 0.00 | 58.27 | 0.00 | 0.00 |